Stockscreener 앱 받기
2.55
1.35%
-0.035
전일 마감가:
$2.585
열려 있는:
$2.57
하루 거래량:
31,703
Relative Volume:
0.43
시가총액:
$37.57M
수익:
-
순이익/손실:
$-2.54M
주가수익비율:
-
EPS:
-
순현금흐름:
$-1.03M
1주 성능:
+27.50%
1개월 성능:
-12.07%
6개월 성능:
+0.00%
1년 성능:
+0.00%
1일 변동 폭
$2.44
$2.75
1주일 범위
$1.90
$2.9799
52주 변동 폭
$1.69
$6.78
Adagio Medical Holdings Inc Stock (ADGM) Company Profile
명칭
Adagio Medical Holdings Inc
전화
212-284-2300
주소
26051 MERIT CIRCLE, LAGUNA HILLS
ADGM을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ADGM
Adagio Medical Holdings Inc
|
2.55 | 37.57M | 0 | -2.54M | -1.03M | 0.00 |
|
ABT
Abbott Laboratories
|
118.95 | 208.18B | 41.22B | 5.77B | 6.49B | 2.94 |
|
SYK
Stryker Corp
|
388.14 | 148.70B | 21.97B | 3.59B | 3.21B | 6.74 |
|
BSX
Boston Scientific Corp
|
90.75 | 133.32B | 15.91B | 1.79B | 1.89B | 0.82 |
|
MDT
Medtronic Plc
|
86.27 | 111.27B | 33.00B | 4.29B | 5.50B | 2.71 |
|
EW
Edwards Lifesciences Corp
|
72.07 | 42.66B | 6.60B | 4.16B | 490.10M | 2.34 |
Adagio Medical Holdings Inc 주식(ADGM)의 최신 뉴스
ADGM stock touches 52-week low at $2.2 amid market shifts - Investing.com Australia
ADGM stock touches 52-week low at $2.2 amid market shifts By Investing.com - Investing.com South Africa
Initial Procedures Completed in Ventricular Tachycardia Cryoablation System Trial - MPO-mag
Adagio Medical Holdings Reports Third Quarter 2024 Earnings - Yahoo Finance
Adagio Medical revenue up 351% in Q3 2024 - Medical Buyer
Adagio Medical Holdings Inc (ADGM) Quarterly 10-Q Report - Quartzy
Stock Market Movers Today • Top Gainers & Losers - Benzinga
Adagio Medical Reports 351% Revenue Surge, Secures CMS Coverage for Cryoablation Device | ADGM Stock News - StockTitan
Perceptive Advisors LLC Acquires Significant Stake in Adagio Med - GuruFocus.com
ADGM Stock Hits 52-Week Low at $2.4 Amid Market Challenges - Investing.com
Tenor Capital Management's Strategic Acquisition of Aeries Techn - GuruFocus.com
Adagio Medical to Present at the Stifel 2024 Healthcare Conference - Marketscreener.com
Adagio Medical's VT Cryoablation System begins pivotal FDA study - Investing.com India
Adagio Medical's VT Cryoablation System begins pivotal FDA study By Investing.com - Investing.com UK
FDA OKs study of Medtronic’s Affera in ventricular tachycardia - BioWorld Online
Adagio Medical Announces Participation in the 19th Annual International Symposium on Ventricular Arrhythmias - The Bakersfield Californian
ADGM stock touches 52-week low at $2.41 amid market challenges By Investing.com - Investing.com South Africa
ADGM stock touches 52-week low at $2.41 amid market challenges - Investing.com
ADGM stock touches 52-week low at $3.51 amid market challenges - Investing.com Australia
Why Intel Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket - Benzinga
Adagio Medical Holdings (NASDAQ:ADGM) Stock Quotes, Forecast and News Summary - Benzinga
Adagio Medical launches VT ablation system in Europe - Investing.com India
Adagio Medical Provides Business Updates - StockTitan
ADGMAdagio Medical Holdings, Inc Latest Stock News & Market Updates - StockTitan
A proxy fight and large sale of Wendy’s shares - II Research
Adagio and ARYA IV combine to form new company focused on cardiac arrhythmia therapies - Cardiac Rhythm News
Adagio Medical goes public in SPAC merger - Mass Device
Reed Smith advises Adagio Medical on closing of business combination with ARYA Sciences Acquisition Corp IV - Reed Smith LLP
Mizuho posts 17.9% Q1 earnings increase, bolstered by Japan's end to deflation - Marketscreener.com
Owens & Minor to acquire Rotech Healthcare for nearly $1.4B - Mass Device
SPAC market diminished but alive despite new SEC rules - BioWorld Online
NASDAQ – Stock Price, Charts & News Today - BNN Bloomberg
ARYA Sciences IV Adds Another Month to Work on Adagio Deal - DealFlow's SPAC News
ARYA IV Updates Investor Presentation on Adagio Deal - DealFlow's SPAC News
Adagio Medical Announces CE Mark approval of VT Cryoablation System, Plans for Immediate Commercialization in Select European Centers - PR Newswire
Reed Smith’s Cheng, Cue named among top lawyers for DeSPAC transactions - Reed Smith LLP
Adagio speeds up financing rhythm with $42M SPAC deal - BioWorld Online
Pulsed Field Ablation (PFA) Market Braces for Surge Beyond US$ 11.7 Million by 2033 - PharmiWeb.com
Adagio Medical Combining with ARYA Sciences IV in $113M Deal - DealFlow's SPAC News
Assure Buys Danam Health To Form $150M Business - Law360
Pulsed Field Ablation Market to Record an Exponential CAGR by 2031Exclusive Report by InsightAce Analytic - Yahoo Finance
AGEDB Inc. Announces Definitive Agreement to be Acquired by Adagio Capital Inc. - PR Newswire
Adagio Medical Announces Initiation and First Procedure in FULCRUM-VT Trial, Starting The Process For Bringing Ultra-Low Temperature Cryoablation for Ventricular Arrhythmias to US Market - PR Newswire
Reed Smith represents Spectral MD on close of business combination with Rosecliff Acquisition Corp I - Reed Smith LLP
Reed Smith represents CorpAcq on business combination with Churchill Capital Corp VII - Reed Smith LLP
Adagio Medical Announces Completion of Enrollment in Cryocure-VT Trial, Maps the Pathway to CE-Mark of vCLAS™ VT Ablation Catheter - PR Newswire
Reed Smith advises Spectral MD Holdings on merger with Rosecliff Acquisition Corp - Reed Smith LLP
Adagio Medical Announces Initiation and First Patient Enrollment in PARALELL Trial To Investigate Safety and Performance of CryoPulse™ Catheter System for Pulsed Field Ablation and Pulsed Field Cryoablation of Persistent Atrial Fibrillation - PR Newswire
New advisory group aims to improve pregnancy, postpartum care in Pa. | Five for the Weekend - Pennsylvania Capital-Star
Reed Smith advises Curtiss-Wright on the sale of Phönix Group to Liberta Partners - Reed Smith LLP
Adagio Medical Announces Successful First-In-Human Cases of Pulsed Field Cryoablation for Treatment of Atrial Fibrillation - PR Newswire
Adagio Medical Holdings Inc (ADGM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.65%
자본화:
|
볼륨(24시간):